D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4576
Proem Acquisition Corp I Warrants
PAACW
| $57.9K | ﹤0.01% |
+150,000
| New | +$43.4K |
2026 Q2
0 quarters
|
|
4577
Xsolla SPAC 1 Warrants
XSLLW
| $57.4K | ﹤0.01% |
240,000
| – | – |
2026 Q1
1 quarter
|
|
4578
Karbon Capital Partners Corp Warrant
KBONW
$3.02M
| $54.1K | ﹤0.01% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
4579
Lexicon Pharmaceuticals
LXRX
$632M
| $53.3K | ﹤0.01% |
+22,200
| New | +$43.2K |
2026 Q2
0 quarters
|
|
4580
D. Boral Acquisition I Corp Warrants
DBCAW
$3.89M
| $52.5K | ﹤0.01% |
150,000
| – | – |
2026 Q1
1 quarter
|
|
4581
ARC Group Acquisition I Corp Warrants
ARCLW
| $51.8K | ﹤0.01% |
+460,000
| New | +$45.9K |
2026 Q2
0 quarters
|
|
4582
Heron Therapeutics
HRTX
$57.5M
| $51.4K | ﹤0.01% |
120,435
-2,480,555
| -95% | -$1.99M |
2016 Q4
38 quarters
|
|
|
GRMLW
4583
Greenland Mines Ltd Warrant
GRMLW
| $51K | ﹤0.01% |
300,000
| – | – |
2022 Q2
16 quarters
|
|
4584
CO2 Energy Transition Corp Right
NOEMR
| $50.4K | ﹤0.01% |
280,000
| – | – |
2025 Q1
5 quarters
|
|
4585
Muzero Acquisition Corp Warrant
MUZEW
| $49.9K | ﹤0.01% |
162,500
| – | – |
2026 Q1
1 quarter
|
|
4586
Meshflow Acquisition Corp Warrants
MESHW
$1.09M
| $47K | ﹤0.01% |
166,666
| – | – |
2026 Q1
1 quarter
|
|
4587
Aimei Health Technology Co Right
AFJKR
| $46.5K | ﹤0.01% |
155,000
| – | – |
2024 Q1
9 quarters
|
|
4588
Spartacus Acquisition Corp II Warrants
TMTSW
$2.38M
| $45K | ﹤0.01% |
+83,333
| New | +$40.4K |
2026 Q2
0 quarters
|
|
4589
PLAYSTUDIOS Inc
MYPS
$45.6M
| $44.4K | ﹤0.01% |
8,901
-7,455
| -46% | -$35.9K |
2023 Q4
10 quarters
|
|
4590
Highview Merger Corp Warrants
HVMCW
| $43.8K | ﹤0.01% |
+125,000
| New | +$38.1K |
2026 Q2
0 quarters
|
|
4591
Solarius Capital Acquisition Corp Warrant
SOCAW
| $43.5K | ﹤0.01% |
150,000
| – | – |
2025 Q3
3 quarters
|
|
4592
Protara Therapeutics
TARA
$138M
| $42.5K | ﹤0.01% |
+11,113
| New | +$52.9K |
2026 Q2
0 quarters
|
|
4593
Mountain Lake Acquisition Corp II Warrants
MLAAW
$2.7M
| $42.2K | ﹤0.01% |
162,500
| – | – |
2026 Q1
1 quarter
|
|
4594
SITE Centers
SITC
$196M
| $40.9K | ﹤0.01% |
10,300
-4,564
| -31% | -$23.8K |
2026 Q1
1 quarter
|
|
|
4595
CO2 Energy Transition Corp Warrant
NOEMW
$691K
| $40.5K | ﹤0.01% |
280,000
| – | – |
2025 Q1
5 quarters
|
|
4596
SBC Medical Group Warrants
SBCWW
$5.18M
| $39.7K | ﹤0.01% |
172,500
| – | – |
2022 Q4
14 quarters
|
|
4597
Fold Holdings Warrant
FLDDW
$623K
| $39.4K | ﹤0.01% |
375,000
| – | – |
2025 Q1
5 quarters
|
|
4598
PUT
Plug Power
PLUG
$1.93B
| $39K | ﹤0.01% |
+14,400
| New | +$45.2K |
2026 Q2
0 quarters
|
|
4599
General Purpose Acquisition Corp Warrant
GPACW
$2.07M
| $39K | ﹤0.01% |
150,000
| – | – |
2026 Q1
1 quarter
|
|
4600
Companhia Siderúrgica Nacional
SID
$1.56B
| $37.5K | ﹤0.01% |
40,988
+133
| +0.3% | +$166 |
2024 Q2
8 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.